CUTIA-B (02487) announced that its Chief Executive Officer and Executive Director, Zhang Lele, has further increased his shareholding.
Kedi-B (02487) issued an announcement, stating that the Board of Directors of the company received a notice from the company's Chief Executive Officer and Executive Director Zhang Lele...
CUTIA-B (02487) announced that the Board of Directors received a notification from the company's CEO and executive director, Zhang Lele, that he personally purchased a total of 5,200 shares of the company on the open market on November 14, 2024, at a total cost of approximately HK$49,600 (increase in shareholding).
Related Articles
New stock news | Hesai (02525) listed on the HKEX main board leading the global intelligent future with Siasun Robot & Automation perception technology.
Strengthening IP and landmark synergy, STARPLUS LEGEND (06683) strategically invested in the Bird's Nest operating company.
IVD MEDICAL (01931) has reached a major strategic cooperation agreement with Renhe International to jointly build the world's first vertical RWA exchange dedicated to the OTC field.
New stock news | Hesai (02525) listed on the HKEX main board leading the global intelligent future with Siasun Robot & Automation perception technology.
Strengthening IP and landmark synergy, STARPLUS LEGEND (06683) strategically invested in the Bird's Nest operating company.
IVD MEDICAL (01931) has reached a major strategic cooperation agreement with Renhe International to jointly build the world's first vertical RWA exchange dedicated to the OTC field.
